
|Videos|August 18, 2022
Patient Profile 1: A Patient With HER2+ Metastatic BC Treated With T-DXd who Develops ILD
After reviewing the historical use of ADCs, panelists discuss the first patient profile of HER2+ metastatic breast cancer managed with trastuzumab deruxtecan.
Advertisement
Episodes in this series

Now Playing
Advertisement
Advertisement
Advertisement
Trending on Oncology Nursing News
1
AI and Oncology Nursing: Detecting Misdiagnosis With Molecular Profiling
2
FDA Approves Gedatolisib for HR+/HER2- Advanced Breast Cancer: What Nurses Need to Know
3
FDA Grants Traditional Approval to Selpercatinib for RET-Fusion Solid Tumors
4
FDA Approves Gedatolisib for HR+/HER2- Metastatic Breast Cancer
5





























































